| phv00259002.v1.p1 |
SUBJID |
Subject ID |
pht005289.v1.p1 |
HER2_Positive_Breast_Cancer_Subject |
| phv00259003.v1.p1 |
CONSENT |
Consent group as determined by DAC |
pht005289.v1.p1 |
HER2_Positive_Breast_Cancer_Subject |
| phv00259004.v1.p1 |
SUBJID |
Subject ID |
pht005290.v1.p1 |
HER2_Positive_Breast_Cancer_Sample |
| phv00259005.v1.p1 |
SAMPID |
Sample ID |
pht005290.v1.p1 |
HER2_Positive_Breast_Cancer_Sample |
| phv00259006.v1.p1 |
SAMPLE_USE |
Method in which sample was analyzed - Seq_DNA_SNP: SNP genotypes derived from sequence data
- Seq_DNA_WholeExome: Whole exome sequencing
|
pht005290.v1.p1 |
HER2_Positive_Breast_Cancer_Sample |
| phv00259007.v1.p1 |
SUBJID |
De-identified Subject ID |
pht005291.v1.p1 |
HER2_Positive_Breast_Cancer_Subject_Phenotypes |
| phv00259008.v1.p1 |
sex |
Gender of participant |
pht005291.v1.p1 |
HER2_Positive_Breast_Cancer_Subject_Phenotypes |
| phv00259009.v1.p1 |
age_at_surgery |
Age at surgical resection |
pht005291.v1.p1 |
HER2_Positive_Breast_Cancer_Subject_Phenotypes |
| phv00259010.v1.p1 |
SAMPID |
De-identified Sample ID |
pht005292.v1.p1 |
HER2_Positive_Breast_Cancer_Sample_Attributes |
| phv00259011.v1.p1 |
ANALYTE_TYPE |
Sample content analyzed |
pht005292.v1.p1 |
HER2_Positive_Breast_Cancer_Sample_Attributes |
| phv00259012.v1.p1 |
IS_TUMOR |
Whether the sample is tumor |
pht005292.v1.p1 |
HER2_Positive_Breast_Cancer_Sample_Attributes |
| phv00259013.v1.p1 |
IS_PDX |
Whether the sample is from patient-derived xenograft (PDX) |
pht005292.v1.p1 |
HER2_Positive_Breast_Cancer_Sample_Attributes |
| phv00259014.v1.p1 |
HISTOLOGICAL_TYPE |
Cell or tissue type or subtype of sample |
pht005292.v1.p1 |
HER2_Positive_Breast_Cancer_Sample_Attributes |
| phv00259015.v1.p1 |
Brain_met_HER2 |
Brain metastases HER2 status |
pht005292.v1.p1 |
HER2_Positive_Breast_Cancer_Sample_Attributes |
| phv00259016.v1.p1 |
Brain_met_ER |
Brain metastases ER status |
pht005292.v1.p1 |
HER2_Positive_Breast_Cancer_Sample_Attributes |
| phv00259017.v1.p1 |
Brain_met_PR |
Brain metastases PR status |
pht005292.v1.p1 |
HER2_Positive_Breast_Cancer_Sample_Attributes |
| phv00259018.v1.p1 |
target_therapy |
Patient target therapy information before surgery |
pht005292.v1.p1 |
HER2_Positive_Breast_Cancer_Sample_Attributes |
| phv00259019.v1.p1 |
chemotherapy |
Patient chemotherapy information before surgery |
pht005292.v1.p1 |
HER2_Positive_Breast_Cancer_Sample_Attributes |
| phv00259020.v1.p1 |
Hormone therapy |
Patient hormone therapy information before surgery |
pht005292.v1.p1 |
HER2_Positive_Breast_Cancer_Sample_Attributes |
| phv00259021.v1.p1 |
Radiation |
Patient radiation information before surgery |
pht005292.v1.p1 |
HER2_Positive_Breast_Cancer_Sample_Attributes |